Accuray Incorporated (LON:0H8I)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.631
+0.050 (3.16%)
At close: Sep 12, 2025

Accuray Company Description

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

In addition, the company offers post-contract customer support, installation, training, and other professional services.

It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.

Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Accuray Incorporated
CountryUnited States
Founded1990
IndustryMedical - Equipment & Services
SectorHealthcare
Employees990
CEOSuzanne Winter

Contact Details

Address:
1240 Deming Way
Madison, Delaware 53717-1954
United States
Phone608 824 2800
Websiteaccuray.com

Stock Details

Ticker Symbol0H8I
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJuly - June
Reporting CurrencyUSD
ISIN NumberUS0043971052
SIC Code3845

Key Executives

NamePosition
Suzanne WinterChief Executive Officer
Ali PervaizChief Financial Officer
Leonel PeraltaChief Operating Officer